The purpose of this study is to see if an investigational drug, GIVinostat, can help treat adults with a blood condition called Polycythemia Vera.

Do you suffer from fibromyalgia? Do you have chronic widespread pain? If so, you may be able to participate in a research study to find out if certain types of light can help with your pain severity and sensitivity. Compensation provided.

We are conducting a research study to evaluate sleep and psychological outcomes in individuals 1-month to 3-months post-ACLR. This will help identify changes after ACLR to help develop future interventions to improve outcomes after ACLR.

Do you spend a large portion of your day sitting? Do you exercise less than 90 minutes per week? If so, you may be able to take part in a study looking at how sitting and movement affect your life. We want to help lower the chances of getting heart disease and diabetes. Compensation provided.

Do you have recurring Chronic Lymphocytic Leukemia? If so, you may be able to take part in a study on two medicines to treat patients whose chronic lymphocytic leukemia has come back. We will also check if this treatment is safe for treatment.

Do you have thyroid cancer? If so, you may be eligible to participate in a research study to see which targeted therapy will work better to prolong the time until your tumor grows or spreads, after initial treatment.

Do you have mycobacterial lung infection (such as MAC or M. Abscessus)? Are you currently receiving treatment for this infection? If so, you may be able to take part in a study to see how well inhaled Clofazimine works to treat mycobacterial lung infections. By taking part, you can receive up to $4,100.

The purpose of this study is to explore how undergraduates use and think about generative AI. I will be conducting a focus group in order to hear directly from students about the ways that they use (or don't use) AI, how they evaluate AI-generated content, what they like about generative AI, and any concerns they have. By learning from students' perspectives, I will gain a better understanding of how to create AI instruction that meets students' needs and interests.

If you have bronchiectasis and have needed antibiotics for worsening symptoms or flare-ups in the past year, you might be eligible to try a new inhaled medication called Ensifentrine. We want to see if this medication can help reduce symptoms and prevent flare-ups. You will be compensated for your participation.

This clinical trial is studying two different investigational treatments for patients with a blood disorder called myelodysplastic syndromes (MDS) who have a specific genetic mutation (IDH1) and have not been treated with certain drugs before. The study will compare the effects of two study drugs, Ivosidenib (IVO) and Azacitidine (AZA), given separately, to see how well they help patients. Researchers will track how many patients experience improvements, how long the treatment effects last, and overall survival.